SUBSTANCE-P INHIBITS THE RELEASE OF ANTERIOR-PITUITARY ADRENOCORTICOTROPIN VIA A CENTRAL MECHANISM INVOLVING CORTICOTROPIN-RELEASING FACTOR-CONTAINING NEURONS IN THE HYPOTHALAMIC PARAVENTRICULAR NUCLEUS

被引:62
作者
LARSEN, PJ
JESSOP, D
PATEL, H
LIGHTMAN, SL
CHOWDREY, HS
机构
[1] CHARING CROSS & WESTMINSTER MED SCH,NEUROENDOCRINOL UNIT,LONDON,ENGLAND
[2] UNIV COPENHAGEN,INST MED ANAT,DEPT B,DK-1168 COPENHAGEN,DENMARK
基金
英国惠康基金;
关键词
SUBSTANCE-P ANTAGONIST; VASOPRESSIN; ADRENOCORTICOTROPIN; INSITU HYBRIDIZATION HISTOCHEMISTRY; CORTICOSTERONE;
D O I
10.1111/j.1365-2826.1993.tb00368.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic osmotic stimulation influences the hypothalamo-adenohypophysial axis by inhibiting the synthesis of hypothalamic corticotrophin-releasing factor (CRF-41) and subsequently the secretion of basal and adrenalectomy-elevated adrenocorticotrophin from the adenohypophysis. In the present study, we used a substance P antagonist to test the hypothesis that this inhibition is mediated centrally by substance P or other tachykinins. In control rats and rats given 2% saline to drink for 12 days, intracerebroventricular administration of a substance P antagonist elevated plasma adrenocorticotrophin and corticosterons levels. Using quantitative in situ hybridization histochemistry, it was also demonstrated that CRF mRNA increased in the medial parvocellular division of the paraventricular nucleus of saline-treated as well as control rats 6 h after intracerebroventricular administration of the antagonist, while vasopressin mRNA in the medial parvocellular division of the paraventricular nucleus was increased in the control animals only. These results provide evidence that central endogenous substance P has an inhibitory influence over the synthesis and release of CRF-41 both under normal conditions and during a chronic osmotic stimulus.
引用
收藏
页码:99 / 105
页数:7
相关论文
共 40 条
[2]  
ARONIN N, 1986, ANNU REV PHYSIOL, V48, P537
[3]   REGIONAL DISTRIBUTION OF SUBSTANCE-P IN BRAIN OF RAT [J].
BROWNSTEIN, MJ ;
MROZ, EA ;
KIZER, JS ;
PALKOVITS, M ;
LEEMAN, SE .
BRAIN RESEARCH, 1976, 116 (02) :299-305
[4]   ALTERED ADRENOCORTICOTROPIN, CORTICOSTERONE AND OXYTOCIN RESPONSES TO STRESS DURING CHRONIC SALT LOAD [J].
CHOWDREY, HS ;
JESSOP, DS ;
PATEL, H ;
LIGHTMAN, SL .
NEUROENDOCRINOLOGY, 1991, 54 (06) :635-638
[5]   SUBSTANCE-P STIMULATES ARGININE VASOPRESSIN AND INHIBITS ADRENOCORTICOTROPIN RELEASE INVIVO IN THE RAT [J].
CHOWDREY, HS ;
JESSOP, DS ;
LIGHTMAN, SL .
NEUROENDOCRINOLOGY, 1990, 52 (01) :90-93
[6]  
COX BF, 1988, EXP BRAIN RES, V70, P61
[7]   A SYNTHETIC PEPTIDE AS AN ANTAGONIST OF SUBSTANCE-P [J].
ENGBERG, G ;
SVENSSON, TH ;
ROSELL, S ;
FOLKERS, K .
NATURE, 1981, 293 (5829) :222-223
[8]   INHIBITION OF CRH-41 RELEASE BY SUBSTANCE-P, BUT NOT SUBSTANCE-K, FROM THE RAT HYPOTHALAMUS INVITRO [J].
FARIA, M ;
NAVARRA, P ;
TSAGARAKIS, S ;
BESSER, GM ;
GROSSMAN, AB .
BRAIN RESEARCH, 1991, 538 (01) :76-78
[9]   BIOLOGICAL EVALUATION OF SUBSTANCE-P ANTAGONISTS [J].
FOLKERS, K ;
HAKANSON, R ;
HORIG, J ;
CHENG, XJ ;
LEANDER, S .
BRITISH JOURNAL OF PHARMACOLOGY, 1984, 83 (02) :449-456
[10]   CORTICOTROPIN RELEASING ACTIVITY OF THE NEW CRF IS POTENTIATED SEVERAL TIMES BY VASOPRESSIN [J].
GILLIES, GE ;
LINTON, EA ;
LOWRY, PJ .
NATURE, 1982, 299 (5881) :355-357